FDA Approved: JULUCA — Original Application (ViiV Healthcare Company)

View source ↗

Summary

FDA approved JULUCA (dolutegravir and rilpivirine) as an oral fixed-dose combination for HIV-1 infection in adults who are virologically suppressed on a stable …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Juluca (dolutegravir + rilpivirine)

Snippet

ORIG AP for JULUCA (DOLUTEGRAVIR SODIUM AND RILPIVIRINE HYDROCHLORIDE)